Physician profile
Sofia Safarova
NPI 1932864121
$685.45
in general payments reported to CMS, 2019-2025
7 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Family Health provider received nationally (typical 2025 total: $209).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.45 · 2022: $59.50 · 2023: $44.70 · 2024: $79.56 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $257.00 | 2025 | Rapiblyk |
| Novo Nordisk INC | $143.44 | 2021-2025 | Ozempic |
| Amgen INC. | $99.78 | 2022-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $62.11 | 2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $57.34 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $39.29 | 2022-2025 | Farxiga |
| Edwards Lifesciences Corporation | $26.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Safarova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.